{"status": "ok", "totalResults": 18, "articles": [{"source": {"id": "cnn", "name": "CNN"}, "author": "By <a href=\"/profiles/aditi-sandal\">Aditi Sangal</a> and <a href=\"/profiles/adrienne-vogt\">Adrienne Vogt</a>, CNN", "title": "The latest on the coronavirus pandemic and the Omicron variant - CNN", "description": "Pfizer and BioNTech announced they have begun a clinical trial for an Omicron-specific Covid-19 vaccine. Follow here for the latest news updates.", "url": "https://www.cnn.com/world/live-news/omicron-variant-coronavirus-news-01-25-22/index.html", "urlToImage": "https://cdn.cnn.com/cnnnext/dam/assets/200213175739-03-coronavirus-0213-super-tease.jpg", "publishedAt": "2022-01-25T14:18:00Z", "content": "Israels Covid-19 advisory panel is officially recommending a fourth vaccine dose for people age 18 and older if more than five months have passed since their third dose.\r\nAccording to the panel, a st\u2026 [+2460 chars]"}, {"source": {"id": null, "name": "News-Medical.Net"}, "author": null, "title": "Immunogenicity to BNT162b2 booster in adults who had previously received inactivated COVID-19 vaccination - News-Medical.Net", "description": "A new preprint available on medRxiv* demonstrates the marked improvement in the immune response when the mRNA vaccine BNT162b2, from Pfizer/BioNTech, is used for the third dose after a primary two-dose series of an inactivated whole virus vaccine.", "url": "https://www.news-medical.net/news/20220125/Immunogenicity-to-BNT162b2-booster-in-adults-who-had-previously-received-inactivated-COVID-19-vaccination.aspx", "urlToImage": "https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_702525_16431190061311176.jpg", "publishedAt": "2022-01-25T14:09:00Z", "content": "The ongoing coronavirus disease 2019 (COVID-19) pandemic has severely disrupted the world in terms of the disease burden and the economic impact of the restrictions imposed on ordinary social interac\u2026 [+6320 chars]"}, {"source": {"id": "ars-technica", "name": "Ars Technica"}, "author": "Eric Berger", "title": "To my surprise and elation, the Webb Space Telescope is really going to work - Ars Technica", "description": "At times, it remains difficult to believe this is really happening.", "url": "https://arstechnica.com/science/2022/01/whats-left-for-the-webb-telescope-now-waggling-mirrors-turning-on-instruments/", "urlToImage": "https://cdn.arstechnica.net/wp-content/uploads/2016/03/614445main_013526_white2-640x215.jpg", "publishedAt": "2022-01-25T13:51:27Z", "content": "The James Webb Space Telescope as it will appear in orbit.\r\n52 with 41 posters participating\r\nI met John Grunsfeld outside a coffee shop in Houston, across the street from Johnson Space Center, a lit\u2026 [+4681 chars]"}, {"source": {"id": "financial-times", "name": "Financial Times"}, "author": null, "title": "Google changes course on cookies plans following advertising industry backlash - Financial Times", "description": "Search giant overhauls central part of new technology designed to replace tracking files over privacy concerns", "url": "https://www.ft.com/content/69b0fdac-1f26-4b10-be25-4efa1aadaf09", "urlToImage": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2F1f38808c-2996-4944-b617-ca470dae182a.jpg?source=next-opengraph&fit=scale-down&width=900", "publishedAt": "2022-01-25T13:00:27Z", "content": "Google has overhauled a central piece of technology it is building to replace advertising cookies, after complaints that it has not done enough to protect users\u2019 privacy and could end up further entr\u2026 [+3107 chars]"}, {"source": {"id": null, "name": "CNA"}, "author": null, "title": "Pfizer and BioNTech launch trial of Omicron-targeted COVID-19 vaccine - CNA", "description": "NEW YORK: Pfizer and BioNTech said on Tuesday (Jan 25) they started a clinical trial to test a new version of their vaccine specifically designed to target the COVID-19 Omicron variant, which has eluded some of the protection provided by the original two-dose\u2026", "url": "https://www.channelnewsasia.com/world/covid-19-omicron-targeted-vaccine-pfizer-biontech-2458731", "urlToImage": "https://onecms-res.cloudinary.com/image/upload/s--rPK0_Pzp--/fl_relative%2Cg_south_east%2Cl_one-cms:core:watermark:reuters%2Cw_0.1/f_auto%2Cq_auto/c_fill%2Cg_auto%2Ch_676%2Cw_1200/v1/one-cms/core/2022-01-25t122633z_3_lynxmpei0o0i1_rtroptp_3_health-coronavirus-vaccine.jpg?itok=d9vttjI5", "publishedAt": "2022-01-25T12:57:54Z", "content": "NEW YORK: Pfizer and BioNTech said on Tuesday (Jan 25) they started a clinical trial to test a new version of their vaccine specifically designed to target the COVID-19 Omicron variant, which has elu\u2026 [+2746 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "Leo Sun", "title": "Microsoft's Purchase of Activision Blizzard Isn't a \"Metaverse\" Play - Motley Fool", "description": "The tech giant is simplifying a complex takeover with a vague buzzword.", "url": "https://www.fool.com/investing/2022/01/25/microsoft-activision-blizzard-isnt-metaverse-play/", "urlToImage": "https://g.foolcdn.com/editorial/images/662309/imagaae1.jpg", "publishedAt": "2022-01-25T12:05:00Z", "content": "Microsoft(NASDAQ:MSFT) recently agreed to buy Activision Blizzard(NASDAQ:ATVI) in a $68.7 billion all-cash deal. It marks Microsoft's biggest acquisition ever and would presumably widen its moat agai\u2026 [+5238 chars]"}, {"source": {"id": null, "name": "TheJournal.ie"}, "author": "AFP", "title": "Pfizer-BioNTech begin enrollments for Omicron-specific vaccine trial - TheJournal.ie", "description": "Pfizer\u2019s CEO Albert Bourla previously said at a conference that the pharmaceutical giant could be ready to file for regulatory approval of the shot by March.", "url": "https://www.thejournal.ie/omicron-vaccine-triall-5664040-Jan2022/", "urlToImage": "https://img2.thejournal.ie/article/5664040/river/?height=400&version=5664052", "publishedAt": "2022-01-25T12:03:00Z", "content": "PFIZER AND BIONTECH have begun enrollment for a clinical trial to test the safety and immune response of their Omicron-specific Covid-19 vaccine in adults aged up to 55, the companies said today.\r\nPf\u2026 [+2483 chars]"}, {"source": {"id": null, "name": "SciTechDaily"}, "author": null, "title": "Extraordinary Black Hole \u2013 Unlike Any Other \u2013 Discovered in Neighboring Galaxy - SciTechDaily", "description": "The discovery, one of the only confirmed intermediate-mass black holes, lives in an equally rare object known as a low-mass, stripped nucleus. Astronomers discovered a black hole unlike any other. At one hundred thousand solar masses, it is smaller than the b\u2026", "url": "https://scitechdaily.com/extraordinary-black-hole-unlike-any-other-discovered-in-neighboring-galaxy/", "urlToImage": "https://scitechdaily.com/images/Supermassive-Black-Hole-Torn-Apart-Star-scaled.jpg", "publishedAt": "2022-01-25T10:33:30Z", "content": "This artist\u2019s impression depicts a black hole. Credit: ESA/Hubble, ESO, M. Kornmesser\r\nThe discovery, one of the only confirmed intermediate-mass black holes, lives in an equally rare object known as\u2026 [+6027 chars]"}, {"source": {"id": null, "name": "GMA News"}, "author": "JON VIKTOR D. CABUENAS, GMA News", "title": "GCash investigating supposed LandBank phishing scam, warns of legal action - GMA News Online", "description": "GCash, operated by Globe Fintech Innovations Inc. (Mynt), on Tuesday said it is looking into reports of e-wallets supposedly at the receiving end of stolen money from accounts of teachers with the Land Bank of the Philippines (LandBank).", "url": "https://www.gmanetwork.com/news/money/companies/819453/gcash-investigating-supposed-landbank-phishing-scam-warns-of-legal-action/story/", "urlToImage": "https://images.gmanews.tv/webpics/2020/09/gcash_2020_09_27_19_24_37.jpg", "publishedAt": "2022-01-25T07:50:04Z", "content": "GCash, operated by Globe Fintech Innovations Inc. (Mynt), on Tuesday said it is looking into reports of e-wallets supposedly at the receiving end of stolen money from accounts of teachers with the La\u2026 [+1861 chars]"}, {"source": {"id": null, "name": "The Straits Times"}, "author": "Hermes Auto", "title": "New therapy to tackle obesity by NTU team uses gel and infrared light, safety shown in trials on mice - The Straits Times", "description": "SINGAPORE - Scientists from Nanyang Technological University (NTU) have developed a therapy that uses a gel and infrared light to burn fat - a possible safer treatment for people working to control their weight.\n. Read more at straitstimes.com.", "url": "https://www.straitstimes.com/singapore/health/new-therapy-to-tackle-obesity-by-ntu-team-uses-gel-and-infrared-light-safety-shown-in-trials-on-mice", "urlToImage": "https://static1.straitstimes.com.sg/s3fs-public/styles/large30x20/public/articles/2022/01/25/yq-ntu1-25012022.jpg?VersionId=redDL2iuMvvONcxJ_A_0rhP2VBhvyTkT", "publishedAt": "2022-01-25T06:31:06Z", "content": "SINGAPORE - Scientists from Nanyang Technological University (NTU) have developed a therapy that uses a gel and infrared light to burn fat - a possible safer treatment for people working to control t\u2026 [+2404 chars]"}, {"source": {"id": "ars-technica", "name": "Ars Technica"}, "author": "Jennifer Ouellette", "title": "Kombucha cultures make excellent sustainable water filters, study finds - Ars Technica", "description": "SCOBY-based membranes are more effective than commercial ones at preventing biofilms.", "url": "https://arstechnica.com/science/2022/01/kombucha-cultures-make-excellent-sustainable-water-filters-study-finds/", "urlToImage": "https://cdn.arstechnica.net/wp-content/uploads/2021/02/kombuchaSCOBY-760x380.jpg", "publishedAt": "2022-01-24T22:06:34Z", "content": "Enlarge/ Close-up of fresh SCOBY (symbiotic culture of bacteria and yeast) used in kombucha.\r\n27 with 24 posters participating\r\nThe refreshing kombucha tea that's all the rage these days among certai\u2026 [+3876 chars]"}, {"source": {"id": null, "name": "AnandTech"}, "author": "Dr. Ian Cutress", "title": "Interview with Intel's Dan Ragland, Head of Overclocking: Tuning Alder Lake For Performance - AnandTech", "description": null, "url": "https://www.anandtech.com/show/17220/interview-with-intels-dan-ragland-head-of-overclocking", "urlToImage": "https://images.anandtech.com/doci/17220/DSC00018_678x452.JPG", "publishedAt": "2022-01-24T14:00:00Z", "content": "The topic of overclocking has been an interesting one to track over the years. Over a decade ago, when dealing with 2-4 core processors, an effective overclock gave a substantial performance uplift, \u2026 [+24116 chars]"}, {"source": {"id": "usa-today", "name": "USA Today"}, "author": "Chandler Hoefle, USA TODAY", "title": "How to sell your old, unwanted tech: Talking Tech podcast - USA TODAY", "description": "How to sell your old, unwanted tech: Talking Tech podcast", "url": "https://www.usatoday.com/story/tech/2022/01/24/how-sell-your-old-unwanted-tech-talking-tech-podcast/6634323001/", "urlToImage": "https://www.gannett-cdn.com/-mm-/925c90cac2950828bbb61819371c14292ee6081b/c=0-0-792-446/local/-/media/2021/12/16/USATODAY/usatsports/Reviewed.com-RvEW-29641-Estradaanton.png?auto=webp&format=pjpg&width=1200", "publishedAt": "2022-01-24T13:42:00Z", "content": "Hit play on the player above to hear the podcast and follow along with the transcript below.This transcript was automatically generated, and then edited for clarity in its current form. There may be \u2026 [+3839 chars]"}]}